Doris Hovgaard

806 total citations
28 papers, 634 citations indexed

About

Doris Hovgaard is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Doris Hovgaard has authored 28 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 16 papers in Hematology and 7 papers in Molecular Biology. Recurrent topics in Doris Hovgaard's work include Hematopoietic Stem Cell Transplantation (11 papers), Neutropenia and Cancer Infections (10 papers) and Hematological disorders and diagnostics (6 papers). Doris Hovgaard is often cited by papers focused on Hematopoietic Stem Cell Transplantation (11 papers), Neutropenia and Cancer Infections (10 papers) and Hematological disorders and diagnostics (6 papers). Doris Hovgaard collaborates with scholars based in Denmark, Sweden and France. Doris Hovgaard's co-authors include Ellen H. Boesen, Lis Adamsen, Mary Jarden, N. I. Nissen, Niels Borregaard, Nis I. Nissen, Ole Weis Bjerrum, Søren Schifter, Maxwell Sehested and Lars Kjeldsen and has published in prestigious journals such as Journal of Clinical Oncology, Heart and British Journal of Haematology.

In The Last Decade

Doris Hovgaard

27 papers receiving 613 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Doris Hovgaard Denmark 13 387 209 197 123 89 28 634
JP Marie France 14 736 1.9× 436 2.1× 161 0.8× 561 4.6× 103 1.2× 26 1.4k
Shu-Huey Chen Taiwan 14 97 0.3× 190 0.9× 82 0.4× 73 0.6× 39 0.4× 29 426
Jiří Vorlíček Czechia 17 268 0.7× 492 2.4× 49 0.2× 227 1.8× 147 1.7× 98 969
Abdullah Al‐Jefri Saudi Arabia 15 116 0.3× 374 1.8× 93 0.5× 138 1.1× 164 1.8× 54 615
Francis Lacombe France 14 141 0.4× 287 1.4× 35 0.2× 190 1.5× 124 1.4× 35 653
Jörn‐Sven Kühl Germany 16 140 0.4× 207 1.0× 133 0.7× 302 2.5× 101 1.1× 43 905
Maarten Egeler Netherlands 11 145 0.4× 258 1.2× 89 0.5× 199 1.6× 95 1.1× 29 769
Amrana Qureshi United Kingdom 10 118 0.3× 379 1.8× 106 0.5× 91 0.7× 168 1.9× 18 653
Narayan R. Shah United States 13 78 0.2× 132 0.6× 124 0.6× 132 1.1× 26 0.3× 22 533
W P Peters United States 5 419 1.1× 362 1.7× 25 0.1× 80 0.7× 163 1.8× 6 738

Countries citing papers authored by Doris Hovgaard

Since Specialization
Citations

This map shows the geographic impact of Doris Hovgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doris Hovgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doris Hovgaard more than expected).

Fields of papers citing papers by Doris Hovgaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doris Hovgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doris Hovgaard. The network helps show where Doris Hovgaard may publish in the future.

Co-authorship network of co-authors of Doris Hovgaard

This figure shows the co-authorship network connecting the top 25 collaborators of Doris Hovgaard. A scholar is included among the top collaborators of Doris Hovgaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doris Hovgaard. Doris Hovgaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Penninga, Elisabeth I, Doris Hovgaard, Aldana Rosso, et al.. (2020). EMA Review of Daratumumab (Darzalex) for the Treatment of Adult Patients Newly Diagnosed with Multiple Myeloma. The Oncologist. 25(12). 1067–1074. 4 indexed citations
2.
Tzogani, Kyriaki, Odoardo Maria Olimpieri, Daniela Melchiorri, et al.. (2019). European Medicines Agency review of ixazomib (Ninlaro) for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. ESMO Open. 4(5). e000570–e000570. 12 indexed citations
3.
Ali, Sahra, Dominik Karres, Justin L. Hay, et al.. (2019). The EMA Review of Mylotarg (Gemtuzumab Ozogamicin) for the Treatment of Acute Myeloid Leukemia. The Oncologist. 24(5). e171–e179. 27 indexed citations
4.
5.
Jarden, Mary, et al.. (2009). The Effect of a Multimodal Intervention on Treatment-Related Symptoms in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Randomized Controlled Trial. Journal of Pain and Symptom Management. 38(2). 174–190. 71 indexed citations
6.
Jarden, Mary, Doris Hovgaard, Ellen H. Boesen, Morten Quist, & Lis Adamsen. (2007). Pilot study of a multimodal intervention: mixed-type exercise and psychoeducation in patients undergoing allogeneic stem cell transplantation. Bone Marrow Transplantation. 40(8). 793–800. 45 indexed citations
7.
Brown, Peter de Nully, et al.. (1998). S-phase induction by interleukin-6 followed by chemotherapy in patients with refractory multiple myeloma. Leukemia Research. 22(11). 983–989. 2 indexed citations
8.
Hovgaard, Doris, Per Stahl Skov, & Nis I. Nissen. (1997). The in vivo Effects of Interleukin‐3 on Histamine Levels in Non‐Hodgkin's Lymphoma Patients. Pharmacology & Toxicology. 80(6). 290–294. 1 indexed citations
9.
Hasselbalch, Hans Carl, Doris Hovgaard, Nis I. Nissen, & Peter Junker. (1995). Serum hyaluronan is increased in malignant lymphoma. American Journal of Hematology. 50(4). 231–233. 21 indexed citations
10.
Hovgaard, Doris, et al.. (1994). Recombinant human interleukin‐3: pharmacokinetics after intravenous and subcutaneous bolus injection and effects on granulocyte kinetics. British Journal of Haematology. 87(4). 700–707. 6 indexed citations
11.
12.
13.
Hovgaard, Doris & N. I. Nissen. (1992). Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with Hodgkin's disease: a phase I/II study.. Journal of Clinical Oncology. 10(3). 390–397. 21 indexed citations
14.
15.
Kjeldsen, Lars, Ole Weis Bjerrum, Doris Hovgaard, et al.. (1992). Human neutrophil gelatinase: A marker for circulating blood neutrophils. Purification and quantitation by enzyme linked immunosorbent assay. European Journal Of Haematology. 49(4). 180–191. 95 indexed citations
16.
17.
Kharazmi, A., Henrik Nielsen, Doris Hovgaard, Niels Borregaard, & N. I. Nissen. (1991). Modulation of neutrophil and monocyte function by recombinant human granulocyte macrophage colony‐stimulating factor in patients with lymphoma. European Journal of Clinical Investigation. 21(2). 219–224. 17 indexed citations
18.
Nissen, Nis I. & Doris Hovgaard. (1991). Controversies in the management of Hodgkin's disease. European Journal of Cancer and Clinical Oncology. 27(3). 306–309. 1 indexed citations
19.
Hovgaard, Doris, Peter Skinhøj, Jette Bangsborg, et al.. (1988). Bacteremia and Candidemia in Hematolpgical Malignancies: Clinical Findings. Scandinavian Journal of Infectious Diseases. 20(5). 495–501. 12 indexed citations
20.
Bruun, Brita, Jette Bangsborg, Doris Hovgaard, & Peter Skinhøj. (1988). Bacteremia and Candidemia in Hematological Malignancies: Microbiological Findings and Antibiotic Susceptibilities. Scandinavian Journal of Infectious Diseases. 20(5). 503–509. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by JP Marie Breakdown of academic impact, for papers by Shu-Huey Chen Breakdown of academic impact, for papers by Jiří Vorlíček Breakdown of academic impact, for papers by Abdullah Al‐Jefri Breakdown of academic impact, for papers by Francis Lacombe Breakdown of academic impact, for papers by Jörn‐Sven Kühl Breakdown of academic impact, for papers by Maarten Egeler Breakdown of academic impact, for papers by Amrana Qureshi Breakdown of academic impact, for papers by Narayan R. Shah Breakdown of academic impact, for papers by W P Peters
Rankless by CCL
2026